{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:56:32Z","timestamp":1774356992069,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T00:00:00Z","timestamp":1455753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ijid.2016.02.013","type":"journal-article","created":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T03:00:45Z","timestamp":1456110045000},"page":"53-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Characteristics of anti-hepatitis C virus antibody-positive patients in a hospital setting in Douala, Cameroon"],"prefix":"10.1016","volume":"45","author":[{"given":"Henry Namme","family":"Luma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Servais Albert Fiacre Bagnaka","family":"Eloumou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Malongue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvis","family":"Temfack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique Noah","family":"Noah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Donfack-Sontsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo Che","family":"Ditah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2016.02.013_bib0150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00042737-200604000-00001","article-title":"Hepatitis C in 2006","volume":"18","author":"Williams","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ijid.2016.02.013_bib0155","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/jama.2011.975","article-title":"Hepatitis C virus infection and coinfection with human immunodeficiency virus: challenges and advancements in management","volume":"306","author":"Hadigan","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2016.02.013_bib0160","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2016.02.013_bib0165","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2016.02.013_bib0170","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","article-title":"The global burden of hepatitis C","volume":"29","author":"Lavanchy","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.ijid.2016.02.013_bib0175","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(06)69374-4","article-title":"Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study","volume":"368","author":"Amin","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2016.02.013_bib0180","unstructured":"World Health Organization. Guidelines for the screening, care and treatment of persons with hepatitis C infection. WHO Geneva; 2014. Accessed January 29, 2015."},{"key":"10.1016\/j.ijid.2016.02.013_bib0185","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2016.02.013_bib0190","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jhep.2005.12.007","article-title":"The coming wave of HCV-related liver disease: dilemmas and challenges","volume":"44","author":"Perz","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2016.02.013_bib0195","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2893.2008.00982.x","article-title":"Cause of death in individuals with chronic HBV and\/or HCV infection, a nationwide community-based register study","volume":"15","author":"Duberg","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ijid.2016.02.013_bib0200","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2471\/BLT.11.097147","article-title":"Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis","volume":"90","author":"Ford","year":"2012","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ijid.2016.02.013_bib0205","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1473-3099(02)00264-5","article-title":"Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa","volume":"2","author":"Madhava","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2016.02.013_bib0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-230X-14-137","article-title":"Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality","volume":"14","author":"Cramp","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ijid.2016.02.013_bib0215","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(14)71045-X","article-title":"Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study","volume":"15","author":"Solomon","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2016.02.013_bib0220","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2334-8-82","article-title":"Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa","volume":"8","author":"Ndong-Atome","year":"2008","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2016.02.013_bib0225","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S0950268804003486","article-title":"Management of chronic hepatitis C in French departments of internal medicine and infectious diseases","volume":"133","author":"Cacoub","year":"2005","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijid.2016.02.013_bib0230","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/gut.44.6.874","article-title":"Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study","volume":"44","author":"Bellentani","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.ijid.2016.02.013_bib0235","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.ijid.2016.02.013_bib0240","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.2496467","article-title":"An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis","volume":"244","author":"Kuo","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.ijid.2016.02.013_bib0245","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/hep.510310332","article-title":"The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States","volume":"31","author":"Armstrong","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.ijid.2016.02.013_bib0250","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/hep.510290528","article-title":"Modeling the hepatitis C virus epidemic in France","volume":"29","author":"Deuffic","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.ijid.2016.02.013_bib0255","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/jmv.10300","article-title":"Hepatitis C virus infection among pregnant women in Yaound\u00e9, Cameroon: prevalence, viremia, and genotypes","volume":"69","author":"Njouom","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijid.2016.02.013_bib0260","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1086\/656233","article-title":"Risk factors for hepatitis C virus transmission in colonial Cameroon","volume":"51","author":"Pepin","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2016.02.013_bib0265","first-page":"67","article-title":"Hepatitis C virus genotypes and viral ribonucleic acid titers in Nigeria","volume":"4","author":"Okwuraiwe","year":"2012","journal-title":"Nigerian Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.ijid.2016.02.013_bib0270","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jmv.20343","article-title":"Hepatitis C virus infection in Cameroon: a cohort-effect","volume":"76","author":"Nerrienet","year":"2005","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijid.2016.02.013_bib0275","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","article-title":"Epidemiology of hepatitis C virus infection","volume":"13","author":"Alter","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ijid.2016.02.013_bib0280","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1086\/498512","article-title":"Hepatitis C virus infection in African Americans","volume":"42","author":"Pearlman","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2016.02.013_bib0285","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/flgastro-2013-100315","article-title":"Extrahepatic manifestations of hepatitis C virus (HCV)","volume":"4","author":"Samuel","year":"2013","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.ijid.2016.02.013_bib0290","first-page":"119","article-title":"Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection","volume":"86","author":"Merican","year":"1993","journal-title":"Q J Med"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971216000333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971216000333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T00:52:22Z","timestamp":1536972742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971216000333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":29,"alternative-id":["S1201971216000333"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2016.02.013","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of anti-hepatitis C virus antibody-positive patients in a hospital setting in Douala, Cameroon","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2016.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}